Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism

TUESDAY, Sept. 5, 2023 -- Apixaban has a lower bleeding risk than warfarin or rivaroxaban during initial treatment for patients with venous thromboembolism (VTE), according to a study published online Aug. 28 in the Journal of Internal...